CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

NCT04224571 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, in Relapse

Interventions

DRUG: Bortezomib Injection
DRUG: rituximab injection

Sponsor

Chinese University of Hong Kong

Collaborators

[object Object]